/QMDT

QMDT Stock - Quick-Med Technologies, Inc.

Q: What is the analyst price target for QMDT?

Analyst price target information is not currently available for QMDT.

Q: What is QMDT's market cap?

Market capitalization information is not currently available for QMDT.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for QMDT

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2008

FY2009

FY2010

FY2011

FY2012

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-39.80

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2012	FY2011	FY2010	FY2009	FY2008
Revenue	$928,493	$997,496	$1.04M	$993,943	$1.00M
Gross Profit	$647,988	$671,619	$692,206	$709,037	$745,383
Gross Margin	69.8%	67.3%	66.6%	71.3%	74.2%
Operating Income	$-376,075	$-1,238,322	$-2,051,789	$-2,084,969	$-1,765,040
Net Income	$-713,073	$-1,686,903	$-2,303,217	$-3,550,165	$-2,022,621
Net Margin	-76.8%	-169.1%	-221.6%	-357.2%	-201.3%
EPS	$-0.02	$-0.05	$-0.07	$-0.11	$-0.07

Company Overview

Quick-Med Technologies, Inc., a life sciences company, focuses on developing and commercializing proprietary broad-based technologies in medical and consumer healthcare markets. It specializes in the research and development of biomedical products and devices for antibacterial applications. The company's core technologies include Novel Intrinsically Micro-Bonded Utility Substrate (NIMBUS), a family of advanced polymers with antimicrobial, hemostatic, and other properties for use in a range of applications; Stay Fresh, a chemical formulation for textiles with a durable antimicrobial agent effective against an array of bacteria; and MultiStat, a family of advanced patented methods and compounds effective in skin therapy applications. It serves government agencies; and healthcare and medical, apparel and textile, and personal care companies. The company was founded in 1997 and is headquartered in Gainesville, Florida.

Visit Website

Frequently Asked Questions about QMDT

What is QMDT's current stock price?

Quick-Med Technologies, Inc. (QMDT) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for QMDT?

No analyst price targets are currently available for this stock.

What sector is Quick-Med Technologies, Inc. in?

Quick-Med Technologies, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is QMDT's market cap?

Quick-Med Technologies, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does QMDT pay dividends?

No, Quick-Med Technologies, Inc. does not currently pay a dividend to shareholders.